Key to informatics initiatives, open model of information sharing,
FREMONT, Calif., Oct. 4 /PRNewswire/ -- The Duke University Health System has licensed Velos eResearch to support its new enterprise-wide strategic business model for clinical trials informatics. Velos, Inc. will play a key role in these clinical trials initiatives, providing the infrastructure to further Duke's commitment to clinical research compliance with regulatory and financial standards supported by technology innovation. The Velos platform will be critical to strategic directions that include collaboration with other institutions on a national and international scale.
"In the world of clinical research, the adequacy of support for research operations is critical, particularly in the form of tools and infrastructure investment," said Steve Woody, Associate CIO for Translational and Clinical Research for Duke Medicine. "Duke has created a strategic business model for the future in this area. We hope to cement and extend leadership among academic centers in supporting investigator- and sponsor-based clinical research."
"It's gratifying to be able to play such an important role in Duke's strategic direction in research," stated John S. McIlwain, President and CEO of Velos. "Duke complements and advances our vision for collaboration and information sharing. We will provide them with the clinical trial technology support they need as they develop their innovative model for Strategic Business Units in clinical research."
Initially, Velos eResearch is being deployed at the Duke Comprehensive
Cancer Center, with a focus on managing patients and trials. That
implementation will move across the health system and affiliates. An
integrated model that will include the financial management of clinical
research is envisioned. Duke will use the Velos core functionality to
create middleware to manage billin
Copyright©2007 PR Newswire.
All rights reserved